Skip to main content
Category

ΔΗΜΟΣΙΟΤΗΤΑ

Backbone and side chain NMR assignments of the H‑NOX domain from Nostoc sp. in complex with BAY58‑2667 (cinaciguat)

By ΔΗΜΟΣΙΕΥΣΕΙΣ, ΔΗΜΟΣΙΟΤΗΤΑ

G I Makrynitsa, A I Argyriou, G Dalkas, D A Georgopoulou, M Bantzi, A Giannis, A Papapetropoulos, G A Spyroulias. Backbone and side chain NMR assignments of the H‑NOX domain from Nostoc sp. in complex with BAY58‑2667 (cinaciguat). Biomol. NMR Assign. 15, 53-57 (2020). doi: 10.1007/s12104-020-09982-3

Read More

In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications

By ΔΗΜΟΣΙΕΥΣΕΙΣ, ΔΗΜΟΣΙΟΤΗΤΑ

K Farsalinos, E Eliopoulos, D D Leonidas, G E Papadopoulos, S Tzartos, K Poulas. Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications. J. Mol. Sci. 21, 5807 (2020). doi: 10.3390/ijms21165807

Read More

1H,13C and 15N chemical shift assignments of the SUD domains of SARS‑CoV‑2 non‑structural protein 3c: “the N‑terminal domain‑SUD‑N

By ΔΗΜΟΣΙΕΥΣΕΙΣ, ΔΗΜΟΣΙΟΤΗΤΑ

A Gallo, A C Tsika, N K Fourkiotis, F Cantini, L  Banci, S  Sreeramulu, H  Schwalbe,  G A Spyroulias. 1H,13C and 15N chemical shift assignments of the SUD domains of SARS‑CoV‑2 non‑structural protein 3c: “the N‑terminal domain‑SUD‑N”. NMR Assign. 15, 85-89 (2020). doi: 10.1007/s12104-020-09987-y

Read More

Multiomics Analysis Coupled with Text Mining Identify Novel Biomarker Candidates for Recurrent Cardiovascular Events

By ΔΗΜΟΣΙΕΥΣΕΙΣ, ΔΗΜΟΣΙΟΤΗΤΑ

C Chalikiopoulou, BJ Bizjan, G Leventopoulos, K Smaili, T Blagus, A Menti, J Liopetas, A John, BR Ali, V Dolzan, GN Hahalis. Multiomics Analysis Coupled with Text Mining Identify Novel Biomarker Candidates for Recurrent Cardiovascular Events. OMICS 24:205-15 Apr 1 (2020). doi: 10.1089/omi.2019.0216

Read More

In vivo biodistribution study of TAT-L-Sco2 fusion protein, developed as protein therapeutic for mitochondrial disorders attributed to SCO2 mutations

By ΔΗΜΟΣΙΕΥΣΕΙΣ, ΔΗΜΟΣΙΟΤΗΤΑ

G C Kaiafas, D Papagiannopoulou, Α N Miliotou, A S Tsingotjidou, P C Chalkidou, A C Tsika, G A Spyroulias, A S Tsiftsoglou, L C Papadopoulou. In vivo biodistribution study of TAT-L-Sco2 fusion protein, developed as protein therapeutic for mitochondrial disorders attributed to SCO2 mutations. Molecular Genetics and Metabolism Report, 25, 100683, (2020). doi: 10.1016/j.ymgmr.2020.100683

Read More